Fundz
Following Duoning Biotech?

Get the free weekly contract digest

The latest new contracts, like Duoning Biotech’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Duoning Biotech partners with Branca Bunús to develop innovative transfection reagents

Nov 06, 2024•over 1 year ago

Contract Type

partnership

ManufacturingBiotechnology

Description

Duoning Biotechnology Group has announced a strategic partnership agreement with Branca Bunús Ltd. to collaborate on the development, optimization, and application of transfection reagents. The goal is to enhance the efficiency of biopharmaceutical development in upstream bioprocess by providing innovative transfection reagents through resource sharing.

Company Information

Company

Duoning Biotech

About

Shanghai Duoning Biotechnology Co., Ltd. is a leading one-stop shop dedicated to providing integrated bioprocess solutions from the development to the commercialization of biologics products in China. We operate two business lines, bioprocess solutions and laboratory products and relative services, and seek to help partners achieve efficient, stable, high-quality and cost-controllable drug development and manufacturing processes. For more information, please visit: www.duoningbio.com.

Predictive Intelligence
Strategic

ML-powered predictions for Duoning Biotech's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.